The KARMET Study
KARMET is a Phase 2b clinical research study evaluating an investigational medication, ENT-01, for Parkinson’s disease with constipation. The purpose of the study is to evaluate the safety and efficacy of ENT-01 in treating constipation associated with Parkinson’s disease.